Breaking News

IX Biopharma Ltd (IXBI)

Singapore

Add to/Remove from Watchlist Add to Watchlist

0.040 -0.005 -11.11%

05:06:00 - Closed. Currency in SGD ( Disclaimer )

Type: Equity

Market: Singapore

ISIN: SG1BD9000009

S/N: 42C

Volume: 189,600
Bid/Ask: 0.039 / 0.040
Day's Range: 0.040 - 0.041

General
Chart
- Streaming Chart
- Interactive Chart
Financials
Technical
Forum

IX Biopharma Ltd Company Profile

Get an in-depth profile of IX Biopharma Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryPharmaceuticals

SectorHealthcare

Employees

Equity Type

ORD

iX Biopharma Ltd., a specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, Europe, the United States, China, and Australia. The company operates through Pharmaceutical and Nutraceutical segments. It offers Wafermine, a sublingual ketamine wafer, which has completed phase-2 clinical trial for the treatment of acute moderate to severe pain and complex regional pain syndrome; Xativa, a sublingual cannabidiol wafer, as well as Hypera, a tetrahydrocannabinol sublingual wafer for the treatment of anxiety, chronic pain, inflammation, and insomnia; and Wafesil and Silcap for the treatment of male erectile dysfunction. The company also provides LumeniX, a sublingual glutathione wafer for skin brightening and immunity; Radiance for reducing wrinkles, smoothening the skin, and promoting a youthful complexion; Regenerate that supports cellular health and aids energy production; WafeRest for the alleviating jetlag and promotion of sleep; and SL-NAD+ supplement products. In addition, it is involved in the development BnoX, a sublingual buprenorphine wafer that is in a phase-1 clinical trial for the management of moderate to severe pain; Dexmedetomidine, which has completed phase-1 clinical trial for agitation in dementia patients; Dronabinol for chemotherapy-induced nausea, vomiting, and anorexia associated with weight loss in patients with HIV/AIDS; IXB-214, which is in phase-1 clinical trial for the treatment of complex regional pain syndrome; IXB-314 that is in phase-1 clinical trial for the treatment-resistant depression; IXB-321, a sublingual vaccine wafer; iXB-322 for respiratory viral prophylaxis; and iXB-320 for anorexia in HIV/chemoinduced nausea and vomiting. iX Biopharma Ltd. was incorporated in 2004 and is headquartered in Singapore.

Contact Information

Address No. 14-01 Great World City East Lobby 1 Kim Seng Promenade
Singapore, 237994
Singapore

Phone 65 6235 2270

Fax 65 6235 2170

Web www.ixbiopharma.com

Top Executives

Name	Age	Since	Title
Shing Tung Ho	55	2013	Non-Executive Non-Independent Director
Yip Hang Lee	68	2008	Executive Chairman & CEO
Patrick Donald Davies	-	2019	Non-Executive Lead Independent Director
Xiwen Tham	-	2022	Independent Non-Executive Director
Vivian Bruce Sunderland	-	-	Member of Scientific Advisory Board
Bob A. Rappaport	-	2016	Member of Scientific Advisory Board
Stephan A. Schug	-	-	Member of Scientific Advisory Board
Yandi Liu	-	2021	Member of Scientific Advisory Board
Woon Keng Teo	-	2022	Independent Non-Executive Director

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

IXBI Comments

Write your thoughts about IX Biopharma Ltd

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Bosch Secret Santa Apr 28, 2020 11:45PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Is it good to hold this long term?

0 0

Report

Forex Signals Jan 28, 2016 5:37AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Downtrend triangle at 0.370

0 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200335025">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="200335025" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="200335025" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200335025">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	37,973.0	+197.6	+0.52%
US 500	4,965.5	-45.6	-0.91%
Dow Jones	37,986.40	+211.02	+0.56%
S&P 500	4,967.23	-43.89	-0.88%
Nasdaq	15,282.01	-319.49	-2.05%
S&P 500 VIX	18.71	+0.71	+3.94%
Dollar Index	105.960	-0.022	-0.02%

Crude Oil WTI	83.25	+0.52	+0.63%
Brent Oil	87.38	+0.27	+0.31%
Natural Gas	1.760	+0.003	+0.17%
Gold	2,406.75	+8.75	+0.36%
Silver	28.747	+0.367	+1.29%
Copper	4.4930	+0.0565	+1.27%
US Soybeans	1,150.50	+15.50	+1.37%

U.S. 10Y	4.623	-0.026	-0.56%
U.S. 30Y	4.713	0.002	0.04%
U.S. 5Y	4.672	0.016	0.34%
U.S. 3M	5.411	+0.014	+0.27%
US 10Y T-Note	107.91	+0.21	+0.20%
Euro Bund	131.04	-0.17	-0.13%
10-2 Yield Spread	-35.57	-0.87	2.51%

Apple	165.00	-2.04	-1.22%
Alphabet A	154.09	-1.92	-1.23%
Tesla	147.05	-2.88	-1.92%
Amazon.com	174.63	-4.59	-2.56%
Netflix	555.04	-55.52	-9.09%
Meta Platforms	481.07	-20.73	-4.13%
Bank of America	36.97	+1.20	+3.35%

Recent Quotes

	Name	Price	Chg.	Chg. %
	IXBI	0.040	-0.005	-11.11%

Market Movers

Name	Last	Chg. %	Vol.
TSLA	147.05	-1.92%	85.13M
NVDA	762.00	-10.00%	83.24M
AMD	146.64	-5.44%	69.79M
AMZN	174.63	-2.56%	52.17M
MSFT	399.12	-1.27%	27.50M
META	481.07	-4.13%	24.64M
SMCI	713.65	-23.14%	17.01M

Name	Last	Chg. %	Vol.
PARA	12.44	+13.40%	42.98M
AXP	231.05	+6.23%	6.88M
FITB	36.25	+5.93%	13.58M
WBA	18.24	+3.70%	10.48M
KMI	18.84	+3.46%	25.44M
BAC	36.97	+3.35%	50.41M
CFG	34.00	+3.34%	6.51M

Name	Last	Chg. %	Vol.
SMCI	713.65	-23.14%	17.01M
NVDA	762.00	-10.00%	83.24M
NFLX	555.04	-9.09%	16.27M
JBL	118.75	-8.36%	2.91M
AMD	146.64	-5.44%	69.79M
MRVL	62.13	-4.77%	12.32M
MPWR	591.52	-4.64%	656.26K